42CAP — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Alp Bio operates a platform that combines human tonsil organoid technology with protein AI models to assess and reduce immunogenicity (anti-drug antibody) risk in therapeutic antibodies before clinical development.
AI & Machine LearningBiotechDeep Tech
Anatol Ehrlich(Founder)in
Co-investorsVenture Kick
ARC is an AI-native finance operating system that consolidates actuals, plan, and forecast data across multiple entities within corporate groups, showing variances (€/%) with drilldown to the booking level.
AI & Machine LearningFintechSaaS
Co-investors468 Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.